Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Feigin

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Evidence from biomarkers and surrogate endpointsAndrew Feigin
Expert Opinion on Emerging Drugs|July 28, 2021
Emerging therapeutics in Huntington's diseaseRobert Wiggins, Andrew Feigin
Neurodegenerative Disease Management|December 18, 2012
Monitoring Huntington's disease progression through preclinical and early stagesChris Tang, Andrew Feigin
Current Opinion in Neurology|August 2, 2002
Recent advances in Huntington's disease: implications for experimental therapeuticsAndrew Feigin, Dennis Zgaljardic
Movement Disorders : Official Journal of the Movement Disorder Society|March 30, 2007
Gene transfer therapy for neurodegenerative disordersAndrew Feigin, David Eidelberg
Current Neurology and Neuroscience Reports|February 15, 2021
Huntington's Disease: New Frontiers in TherapeuticsLing Pan, Andrew Feigin
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 17, 2013
Gene-based therapies in Parkinson's diseasePatricia J Allen, Andrew Feigin
Neurologic Clinics|April 14, 2020
Medical, Surgical, and Genetic Treatment of Huntington DiseaseChristine M Stahl, Andrew Feigin
Current Neurology and Neuroscience Reports|June 26, 2004
Neuroimaging of Parkinson's disease and atypical parkinsonismDennis J Zgaljardic, Andrew Feigin
Cold Spring Harbor Perspectives in Medicine|May 4, 2012
Functional neuroimaging in Parkinson's diseaseMartin Niethammer, Andrew Feigin, David Eidelberg
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Evidence from biomarkers and surrogate endpointsAndrew Feigin
Expert Opinion on Emerging Drugs|July 28, 2021
Emerging therapeutics in Huntington's diseaseRobert Wiggins, Andrew Feigin
Neurodegenerative Disease Management|December 18, 2012
Monitoring Huntington's disease progression through preclinical and early stagesChris Tang, Andrew Feigin
Current Opinion in Neurology|August 2, 2002
Recent advances in Huntington's disease: implications for experimental therapeuticsAndrew Feigin, Dennis Zgaljardic
Movement Disorders : Official Journal of the Movement Disorder Society|March 30, 2007
Gene transfer therapy for neurodegenerative disordersAndrew Feigin, David Eidelberg
Current Neurology and Neuroscience Reports|February 15, 2021
Huntington's Disease: New Frontiers in TherapeuticsLing Pan, Andrew Feigin
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 17, 2013
Gene-based therapies in Parkinson's diseasePatricia J Allen, Andrew Feigin
Neurologic Clinics|April 14, 2020
Medical, Surgical, and Genetic Treatment of Huntington DiseaseChristine M Stahl, Andrew Feigin
Current Neurology and Neuroscience Reports|June 26, 2004
Neuroimaging of Parkinson's disease and atypical parkinsonismDennis J Zgaljardic, Andrew Feigin
Cold Spring Harbor Perspectives in Medicine|May 4, 2012
Functional neuroimaging in Parkinson's diseaseMartin Niethammer, Andrew Feigin, David Eidelberg
Pageof 7